Share
235 Posts.
lightbulb Created with Sketch. 164
clock Created with Sketch. 07/07/23
12:34
Share
Originally posted by variouscoffee:
↑
Reading between the lines here is quite interesting. I was initially underwhelmed with the Sheba 2 update based on the wording, but I am personally unsure of what good/bad results here look like due to the heavily pre-treated condition of patients. Thankfully, the planned actions of the company indicate the importance of the result to date:
Expand
The EMD AML approval pathway is where we have already sunk costs for FDA advisors and the FDA strategy meeting regarding an IND. So even with partnership talks we reserve the right to go it alone, at least helpful in negotiations if not reality
